Table I.
Comparison of hematological aspects: children with falciparum, vivax malaria and healthy
| Group | HGB g/dl | HCT % |
MCV fl |
MCH pg |
RBC µl |
WBC
µl |
Plt µl |
|---|---|---|---|---|---|---|---|
| falciparum Patients | 10.21±0.62 MD=10.25 |
34.92±1.4 MD=35.55 |
72.73±4.75 MD=71.55 |
19.9±0.54 MD=19.93 |
4.84±0.12 MD=4.85 |
5.09±0.35 MD=5.25 |
263.8±59.64 MD=280.5 |
| vivax patients | 12.2±0.75 MD=12.25 |
37.5±1.62 MD=37.75 |
73.48±0.84 MD=73.35 |
23.61±0.76 MD=23.25 |
4.8±0.52 MD=4.79 |
11.5±0.41 MD=11.55 |
408.2±328.73 MD=328 |
| Healthy | 26.44±40.3 MD=13.65 |
41.31±3.75 MD=40.75 |
84.66±3.32 MD=85.5 |
27.88±0.91 MD=27.9 |
5.02±0.53 MD=4.92 |
8.81±3.36 MD=8.35 |
317.1±92.15 MD=302 |
| Test | Kruskal-Wallis Test | ANOVA | ANOVA | ANOVA | ANOVA | ANOVA | Kruskal-Wallis Test |
| P-value | <0.001 | <0.001 | <0.001 | <0.001 | 0.49 | <0.001 | 0.002 |